Safety and Efficacy of 2% Crisaborole Ointment in Adults Aged ≥45 with Stasis Dermatitis
The following is a summary of "Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study," published in the May 2024 issue of Dermatology...